Investors Helping Investors Beat the Market
Results 1 - 10 of 79 : 1 2 3 4 5 6 7 8 Next
A new study indicates CEO compensation has correlated with stock performance.
Mylan Beats Analyst Estimates on EPS
Just the facts, Fool.
Has Mylan Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
Mylan Misses on Revenues but Beats on EPS
Just the facts, Fool.
These two metrics can tell you a lot.
Are these stocks ready to take on the market in a rubber match?
Mylan's Growth May Not Be What It Seems
These two simple metrics can save you a lot of pain.
When You Need More Than Just a Low-Margin Business
Generic drugs and then some.
12 Pharmaceutical Stocks the Insiders Are Buying
Folks in the know think these stocks will rise. Should you join them?
The Tale of 2 Generic-Drug Makers
Teva and Mylan post strong quarters through wildly different means.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK